# Adaptimmune Therapeutics PLC: Form DEF 14A, filed Apr 13, 2023

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: DEF 14A
- Filed: 2023-04-13
- Accepted by EDGAR: Apr 13, 2023, 08:00 ET
- Period: not reported
- Accession: 0001104659-23-044825
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000110465923044825/tm231869d4_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000110465923044825/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000110465923044825/tm231869d4_def14a.htm

Filed Apr 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-044825. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.
